DK1711502T3 - Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater - Google Patents

Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater

Info

Publication number
DK1711502T3
DK1711502T3 DK05712726T DK05712726T DK1711502T3 DK 1711502 T3 DK1711502 T3 DK 1711502T3 DK 05712726 T DK05712726 T DK 05712726T DK 05712726 T DK05712726 T DK 05712726T DK 1711502 T3 DK1711502 T3 DK 1711502T3
Authority
DK
Denmark
Prior art keywords
protected
dieneol
carboxylates
preparing
methods
Prior art date
Application number
DK05712726T
Other languages
Danish (da)
English (en)
Inventor
Andreas Stumpf
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34860329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1711502(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1711502T3 publication Critical patent/DK1711502T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DK05712726T 2004-02-06 2005-02-04 Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater DK1711502T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54271104P 2004-02-06 2004-02-06
PCT/US2005/003390 WO2005077957A2 (en) 2004-02-06 2005-02-04 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates

Publications (1)

Publication Number Publication Date
DK1711502T3 true DK1711502T3 (da) 2008-12-01

Family

ID=34860329

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07014411.8T DK1864987T3 (da) 2004-02-06 2005-02-04 Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater
DK05712726T DK1711502T3 (da) 2004-02-06 2005-02-04 Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07014411.8T DK1864987T3 (da) 2004-02-06 2005-02-04 Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater

Country Status (34)

Country Link
US (6) US8003793B2 (de)
EP (3) EP1711502B1 (de)
JP (1) JP4963968B2 (de)
KR (4) KR20070108956A (de)
CN (1) CN1918168B (de)
AP (1) AP2006003716A0 (de)
AT (2) ATE406372T1 (de)
AU (1) AU2005212258B2 (de)
BR (1) BRPI0506607B8 (de)
CA (2) CA2555215C (de)
CR (1) CR8590A (de)
CY (2) CY1108506T1 (de)
DE (2) DE602005009321D1 (de)
DK (2) DK1864987T3 (de)
EA (2) EA012905B1 (de)
EC (1) ECSP066824A (de)
ES (2) ES2338054T3 (de)
GE (1) GEP20084454B (de)
HK (2) HK1103071A1 (de)
HR (2) HRP20080618T3 (de)
IL (2) IL177281A (de)
MA (1) MA28346A1 (de)
MX (1) MXPA06008931A (de)
NO (2) NO20063989L (de)
NZ (2) NZ548786A (de)
PL (2) PL1864987T3 (de)
PT (2) PT1864987E (de)
RS (2) RS51317B (de)
SG (1) SG150500A1 (de)
SI (2) SI1711502T1 (de)
TN (1) TNSN06248A1 (de)
UA (2) UA88646C2 (de)
WO (1) WO2005077957A2 (de)
ZA (1) ZA200606252B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20084454B (en) 2004-02-06 2008-08-10 Euro Celtique Sa Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
RU2009112685A (ru) * 2006-09-20 2010-10-27 Маллинкродт Инк. (Us) Получение замещенных морфинан-6-онов и их солей и промежуточных соединений
US9040726B2 (en) 2007-03-06 2015-05-26 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
PL2147920T3 (pl) * 2007-03-06 2017-02-28 Mallinckrodt Llc Sposób wytwarzania czwartorzędowych N-alkilowych soli alkaloidu morfinanowego
US8148528B2 (en) 2008-05-27 2012-04-03 Mallinckrodt Llc Processes and compounds for the preparation of normorphinans
US9458109B2 (en) * 2008-09-03 2016-10-04 Mallinckrodt Llc Substituted berbines and processes for their synthesis
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives
CN102946870A (zh) 2010-05-10 2013-02-27 欧洲凯尔特公司 包含氢吗啡酮和纳洛酮的药物组合物
EP2568968B1 (de) 2010-05-10 2017-07-12 Euro-Celtique S.A. Herstellung von Wirkstoff-freiem Granulat und dieses enthaltende Tabletten
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
EP3357898B1 (de) 2015-09-30 2020-11-25 FUJIFILM Wako Pure Chemical Corporation Verfahren zur herstellung einer organischen verbindung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654756A (en) 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
DE902257C (de) 1951-07-17 1954-01-21 Knoll Ag Verfahren zur Herstellung von Acylderivaten der Enolform des Codeinons
GB1495271A (en) * 1974-04-10 1977-12-14 Macfarlan Smith Ltd Dehydrohalogenation of codeinone derivatives
US4472253A (en) 1981-08-17 1984-09-18 The Florida Board Of Regents On Behalf Of The Florida State University Process for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivative
US5112975A (en) 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine
SE9003665D0 (sv) 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
US5821374A (en) 1995-11-21 1998-10-13 Hoffmann-La Roche Inc. Process for the oxidation of alcohols
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
GB9713703D0 (en) * 1997-06-30 1997-09-03 Johnson Matthey Plc Preparation of opiates
US6177567B1 (en) 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
US6596877B2 (en) 2001-10-17 2003-07-22 Novartis Ag Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols
GEP20084454B (en) 2004-02-06 2008-08-10 Euro Celtique Sa Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates

Also Published As

Publication number Publication date
UA88646C2 (uk) 2009-11-10
BRPI0506607A (pt) 2007-05-02
WO2005077957A3 (en) 2006-05-04
EP1864987A3 (de) 2008-02-20
KR100921696B1 (ko) 2009-10-15
RS50663B (sr) 2010-06-30
NO20063989L (no) 2006-10-31
KR20070026401A (ko) 2007-03-08
ES2313299T3 (es) 2009-03-01
KR20070117701A (ko) 2007-12-12
NZ565355A (en) 2008-09-26
SI1864987T1 (sl) 2010-04-30
ATE406372T1 (de) 2008-09-15
HRP20100123T1 (hr) 2010-04-30
EP1864987A2 (de) 2007-12-12
IL177281A0 (en) 2006-12-10
US20120225902A1 (en) 2012-09-06
CA2808199A1 (en) 2005-08-25
KR100921695B1 (ko) 2009-10-15
MXPA06008931A (es) 2007-01-26
CY1108506T1 (el) 2014-04-09
KR101011460B1 (ko) 2011-01-28
US8975257B2 (en) 2015-03-10
EP1711502A2 (de) 2006-10-18
EP1711502B1 (de) 2008-08-27
DE602005009321D1 (de) 2008-10-09
ECSP066824A (es) 2006-12-29
US20140171643A1 (en) 2014-06-19
US8003793B2 (en) 2011-08-23
EA016062B1 (ru) 2012-01-30
EP1864987B1 (de) 2009-12-09
CY1109838T1 (el) 2014-09-10
PT1711502E (pt) 2008-11-20
CA2555215C (en) 2013-05-21
SG150500A1 (en) 2009-03-30
SI1711502T1 (sl) 2009-02-28
RS51317B (sr) 2010-12-31
GEP20084454B (en) 2008-08-10
CR8590A (es) 2007-07-19
JP4963968B2 (ja) 2012-06-27
BRPI0506607B8 (pt) 2021-05-25
US20120022259A1 (en) 2012-01-26
JP2007520563A (ja) 2007-07-26
AU2005212258B2 (en) 2008-05-22
IL177281A (en) 2012-02-29
CN1918168B (zh) 2011-04-27
HK1119160A1 (en) 2009-02-27
ATE451374T1 (de) 2009-12-15
US20150239898A1 (en) 2015-08-27
US20080146804A1 (en) 2008-06-19
PT1864987E (pt) 2010-03-09
EA200601394A1 (ru) 2006-12-29
EP2194059A2 (de) 2010-06-09
US8685996B2 (en) 2014-04-01
CA2555215A1 (en) 2005-08-25
US8198444B2 (en) 2012-06-12
ES2338054T3 (es) 2010-05-03
NZ548786A (en) 2008-08-29
EA012905B1 (ru) 2010-02-26
WO2005077957A2 (en) 2005-08-25
CA2808199C (en) 2015-10-27
EA200801811A1 (ru) 2008-12-30
PL1711502T3 (pl) 2009-02-27
EP2194059A3 (de) 2010-09-22
TNSN06248A1 (fr) 2007-12-03
NO339083B1 (no) 2016-11-14
ZA200606252B (en) 2007-11-28
US9670218B2 (en) 2017-06-06
KR20090089486A (ko) 2009-08-21
AU2005212258A1 (en) 2005-08-25
DE602005018265D1 (de) 2010-01-21
IL205596A (en) 2011-11-30
NO20150276L (no) 2006-10-31
BRPI0506607B1 (pt) 2018-01-16
MA28346A1 (fr) 2006-12-01
PL1864987T3 (pl) 2010-05-31
KR20070108956A (ko) 2007-11-13
UA87833C2 (uk) 2009-08-25
HRP20080618T3 (en) 2009-01-31
AP2006003716A0 (en) 2006-08-31
HK1103071A1 (en) 2007-12-14
DK1864987T3 (da) 2010-04-12
US20170233400A1 (en) 2017-08-17
CN1918168A (zh) 2007-02-21

Similar Documents

Publication Publication Date Title
DK1711502T3 (da) Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater
DK1924577T3 (da) Substituerede benzimidazoler og fremgangsmåder til fremstilling
NO2017017I1 (no) umeklinidium og vilanterol
IS8204A (is) Tæki og aðferð til að hluta niður
DK1934179T3 (da) Fremgangsmåder og mellemprodukter
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
DK3144240T3 (da) Stabelbar pakning og fremgangsmåde til tilvejebringelse heraf
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK2479259T3 (da) Multi-kryokonserverede hepatocytter og fremgangsmåder til fremstillilng deraf
DK1712728T3 (da) Rörelevator og fremgangsmåde
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK1907628T3 (da) Kunstgræsstruktur og fremgangsmåde til fremstilling deraf
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK2120591T3 (da) Ny drikkeyoghurt og fremgangsmåde til fremstilling deraf
DK1760156T3 (da) Materialer og fremgangsmåder til effektiv mælkesyrefremstilling
DK1824475T3 (da) Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK1965763T3 (da) Stabile enzympræparater og fremgangsmåder til anvendelse heraf
DK2308900T3 (da) Immunogene sammensætninger og fremgangsmåder til anvendelse
DK1874557T3 (da) Identitetsdokument og fremgangsmåde til fremstilling deraf
DK1922309T3 (da) N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf
DK2019090T3 (da) Substitueret beta-phenyl-alfa-hydroxypropansyre, fremgangsmåde til syntese og anvendelse deraf
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1786680T3 (da) Beskyttet hætteglas og fremgangsmåde til fremstilling heraf